360 related articles for article (PubMed ID: 28056852)
1. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
[TBL] [Abstract][Full Text] [Related]
2. Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002-2011.
Ozieh MN; Bishu KG; Dismuke CE; Egede LE
BMC Health Serv Res; 2017 May; 17(1):368. PubMed ID: 28532412
[TBL] [Abstract][Full Text] [Related]
3. Assessing key cost drivers associated with caring for chronic kidney disease patients.
Damien P; Lanham HJ; Parthasarathy M; Shah NL
BMC Health Serv Res; 2016 Dec; 16(1):690. PubMed ID: 28031020
[TBL] [Abstract][Full Text] [Related]
4. Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011.
Ozieh MN; Dismuke CE; Lynch CP; Egede LE
Diabetes Res Clin Pract; 2015 Jul; 109(1):185-90. PubMed ID: 25935258
[TBL] [Abstract][Full Text] [Related]
5. Chronic condition combinations and health care expenditures and out-of-pocket spending burden among adults, Medical Expenditure Panel Survey, 2009 and 2011.
Meraya AM; Raval AD; Sambamoorthi U
Prev Chronic Dis; 2015 Jan; 12():E12. PubMed ID: 25633487
[TBL] [Abstract][Full Text] [Related]
6. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
7. Trends of medical expenditures and quality of life in US adults with diabetes: the medical expenditure panel survey, 2002-2011.
Campbell JA; Bishu KG; Walker RJ; Egede LE
Health Qual Life Outcomes; 2017 Apr; 15(1):70. PubMed ID: 28407776
[TBL] [Abstract][Full Text] [Related]
8. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
9. Co-occurring Chronic Conditions and Economic Burden among Stroke Survivors in the United States: A Propensity Score-Matched Analysis.
Chinthammit C; Coull BM; Nimworapan M; Bhattacharjee S
J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):393-402. PubMed ID: 27793537
[TBL] [Abstract][Full Text] [Related]
10. Monthly direct and indirect costs of management of CKD 3 - 5 non-dialysis patients in an out-of-pocket expenditure system: The Case of Yaoundé.
Ngeugoue FT; Njoumemi Z; Kaze FF
Clin Nephrol; 2020; 93(1):100-102. PubMed ID: 31397268
[TBL] [Abstract][Full Text] [Related]
11. Direct Medical Expenditures Associated with Eye Complications among Adults with Diabetes in the United States.
Meraya AM; Alwhaibi M; Khobrani MA; Makeen HA; Alqahtani SS; Banji D
J Diabetes Res; 2020; 2020():2864069. PubMed ID: 32509878
[TBL] [Abstract][Full Text] [Related]
12. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
Patel AR; Dombrovskiy VY; Vogel TR
Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
[TBL] [Abstract][Full Text] [Related]
13. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
Yusuf AA; Howell BL; Powers CA; St Peter WL
Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203
[TBL] [Abstract][Full Text] [Related]
14. Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.
Roggeri A; Roggeri DP; Zocchetti C; Bersani M; Conte F; ;
J Nephrol; 2017 Apr; 30(2):263-269. PubMed ID: 27165160
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of patients with anemia in selected diseases.
Ershler WB; Chen K; Reyes EB; Dubois R
Value Health; 2005; 8(6):629-38. PubMed ID: 16283863
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States.
St Peter WL; Guo H; Kabadi S; Gilbertson DT; Peng Y; Pendergraft T; Li S
BMC Nephrol; 2018 Mar; 19(1):67. PubMed ID: 29544446
[TBL] [Abstract][Full Text] [Related]
17. Costs of patients with chronic kidney disease in Germany.
Gandjour A; Armsen W; Wehmeyer W; Multmeier J; Tschulena U
PLoS One; 2020; 15(4):e0231375. PubMed ID: 32330140
[TBL] [Abstract][Full Text] [Related]
18. Differences in medical care expenditures for adults with depression compared to adults with major chronic conditions.
Lurie IZ; Manheim LM; Dunlop DD
J Ment Health Policy Econ; 2009 Jun; 12(2):87-95. PubMed ID: 19567934
[TBL] [Abstract][Full Text] [Related]
19. Estimating annual medical and out-of-pocket expenditures associated with traumatic injuries in the United States.
Alghnam S; Vanness DJ; Gaskin DJ; Thorpe RJ; Castillo R
J Trauma Acute Care Surg; 2016 Feb; 80(2):258-64. PubMed ID: 26517784
[TBL] [Abstract][Full Text] [Related]
20. Cost to government and society of chronic kidney disease stage 1-5: a national cohort study.
Wyld ML; Lee CM; Zhuo X; White S; Shaw JE; Morton RL; Colagiuri S; Chadban SJ
Intern Med J; 2015 Jul; 45(7):741-7. PubMed ID: 25944415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
